New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2016, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
View latest version (2016)Bibliographic information
GuidelineAntiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings : towards universal access : recommendations for a public health approach
Year of Publication2006
Issuing InstitutionWorld Health Organization
Recommendation
Retired
If stavudine (d4T) or zidovudine (AZT) has been used in first-line therapy, use tenofovir disoproxil fumarate (TDF) + (3TC) or emtricitabine (FTC) as the nucleoside reverse transcriptase inhibitor (NRTI) backbone in second- line therapy
Recommended in favor
Strong
Certainty of evidence
Moderate